NBP News & Events

NovaBridge Biosciences named Emmett Cunningham, Jr, MD, PhD, MPH, Co-Founder and Executive Chairman of Visara, as Vice Chairman of the NovaBridge Board of Directors. Dr. Cunningham will also join the Research and Development Committee of the Board.

NovaBridge announced enrollment of the first patient in the global Phase 2 randomized combination study evaluating givastomig, a Claudin 18.2 x 4-1BB bispecific antibody, in combination with nivolumab and chemotherapy in patients with HER2-negative, 1L metastatic gastric cancer.